---
$id: https://graph.org.ai/products/commodity/51161532
$type: Product
source: UNSPSC
code: "51161532"
title: "Binizolast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Binizolast

**UNSPSC Code**: 51161532
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C18H23N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W2KGP0434Y, chemically known as 1-(piperidinomethyl)-4-propyl-s-triazolo(4,3-a)quinazolin-5(4h)-one but generally known as binizolast, which bears US NIH Compound Identifier 185461. European Medicines Agency schedules Binizolast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05838MIG. The term BINIZOLAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). BINIZOLAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule binizolast under HS 29335995 and SITC 51576. As of Q4 2014, BINIZOLAST remains the US FDA Preferred Term for this commodity. Binizolast bears US NLM identifiers UMLS ID C2347021 and NCI Concept Code C74130. SMILES: O=C1N(C2N(C(NN2)CN2CCCCC2)C2C1CCCC2)CCC.

